Canada: Pfizer COVID-19 vaccine as booster shot approved for teens aged 16 and 17
- Subversive discovery: Can lymph nodes promote the success of cancer immunotherapy?
- Major Discovery: Cancer cell PD-L1 does not inhibit T cell toxicity
- The new coronavirus may kill cancer cells and achieve a permanent cure!
- Why did the Alzheimer’s drug candidate BACE1 inhibitor fail?
- LRTI Death: Research spanning 80 years confirms for the first time
- The decline of the global antibiotic market is threatening the development of new drugs
Canada: Pfizer COVID-19 vaccine as booster shot approved for teens aged 16 and 17
- More than 1 million Chinese died after China quit “Zero-COVID policy”?
- Why is Vinyl chloride listed as a Class A “known human carcinogen” ?
- First human trial of HIV gene therapy: A one-time cure will be achieved if successful!
- New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
Canada: Pfizer COVID-19 vaccine as booster shot approved for teens aged 16 and 17.
Health Canada on Wednesday approved a single-dose booster of Pfizer and its partner BioNTech’s coronavirus vaccine for 16- and 17-year-olds.
Last November, Canada’s health regulator approved a booster dose for people 18 and older.
Boosters are usually given 6 months after the first two doses of the vaccine.
The latest decision is based on data from two studies of booster injections in people 16 and older.
In addition, the agency said the vaccine’s label included a potential side effect risk of myocarditis and pericarditis.
These side effects were reported following injections of the Pfizer and Moderna vaccines, especially in younger men.
Teenagers aged 12 to 17 are affected by the COVID-19
In January, the National Advisory Council on Immunization of Canada (NACI) said in an updated guideline that adolescents between the ages of 12 and 17 are vulnerable to the coronavirus and should therefore receive boosters.
For children and adolescents, Pfizer’s vaccine is more popular than Moderna because there isn’t much data and information on Moderna’s use in this population, the NACI said.
In the U.S., Pfizer and BioNTech make boosters approved for use in children under 5 years of age.
Last year, some researchers said they saw a link between vaccines using mRNA technology and myocarditis in a small number of people.
Still, there is an overwhelming consensus among experts that the effects of the vaccine outweigh the risk of side effects, as contracting Covid-19 poses a serious threat to heart health.
(source:internet, reference only)
Disclaimer of medicaltrend.org
